Similar results were obtained in human prostate adenocarcinoma LNCaP cells and on PC-3 prostate cancer cells TRAIL-resistant that after treatment with resveratrol showed an enhancement of DR4 and DR5 surface expression. The gene discussed is TNFRSF10B; the disease is prostate carcinoma.